Results
11
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
11 companies
Celon Pharma
Market Cap: zł1.2b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł21.80
7D
-1.8%
1Y
-21.7%
Selvita
Market Cap: zł693.8m
Operates as a contract research organization worldwide.
SLV
zł37.80
7D
14.9%
1Y
-33.3%
BIOTON
Market Cap: zł390.7m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.55
7D
1.3%
1Y
35.8%
Mabion
Market Cap: zł144.7m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł8.95
7D
-2.1%
1Y
-46.6%
Poltreg
Market Cap: zł119.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł25.70
7D
-2.7%
1Y
-52.4%
Read-Gene
Market Cap: zł80.9m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł6.86
7D
18.3%
1Y
17.9%
Biogened
Market Cap: zł60.9m
Develops, produces, and distributes pharmaceutical products in Poland.
BGD
zł24.80
7D
0%
1Y
-2.4%
Genomed Spólka Akcyjna
Market Cap: zł36.5m
Provides DNA sequencing and analysis, and diagnostics of congenital diseases in Poland.
GEN
zł27.60
7D
-0.7%
1Y
2.2%
genXone
Market Cap: zł19.4m
Operates in the biotechnology industry in Poland and internationally.
GX1
zł5.86
7D
7.3%
1Y
12.3%
Stem Cells Spin
Market Cap: zł17.6m
Operates as a biotechnology company in Poland.
SCS
zł0.43
7D
-2.3%
1Y
102.9%
Labocanna
Market Cap: zł6.1m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.29
7D
0.7%
1Y
-19.9%